AMBERLY SMITH: Open Payments
NPI 1568014751 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,022 in 153 payments from 22 companies in 2025. Trend: 2023 $1,640 · 2024 $1,960 · 2025 $3,022
Food & beverage: $3,022
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $553 |
| Phathom Pharmaceuticals, Inc. | 16 | $409 |
| AstraZeneca Pharmaceuticals LP | 10 | $295 |
| Novo Nordisk Inc | 11 | $262 |
| Axsome Therapeutics, Inc. | 8 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $182 |
| Astellas Pharma US Inc | 9 | $174 |
| Otsuka America Pharmaceutical, Inc. | 3 | $157 |
| PFIZER INC. | 11 | $150 |
| Antares Pharma, Inc. | 11 | $136 |
Products named: VOQUEZNA, VRAYLAR, AIRSUPRA, CAPLYTA, Ozempic, Veozah, REXULTI, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
